0001842952-24-000042.txt : 20240614 0001842952-24-000042.hdr.sgml : 20240614 20240614074142 ACCESSION NUMBER: 0001842952-24-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERMAN RICHARD J CENTRAL INDEX KEY: 0001111620 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40654 FILM NUMBER: 241043161 MAIL ADDRESS: STREET 1: 305 COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Context Therapeutics Inc. CENTRAL INDEX KEY: 0001842952 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863738787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-225-7416 MAIL ADDRESS: STREET 1: 2001 MARKET STREET STREET 2: SUITE 3915 UNIT #15 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FORMER COMPANY: FORMER CONFORMED NAME: Context Therapeutics LLC DATE OF NAME CHANGE: 20210128 4 1 wk-form4_1718365295.xml FORM 4 X0508 4 2024-06-13 0 0001842952 Context Therapeutics Inc. CNTX 0001111620 BERMAN RICHARD J 2001 MARKET STREET SUITE 3915, UNIT #15 PHILADELPHIA PA 19103 1 0 0 0 0 Stock Option (right to buy) 1.97 2024-06-13 4 A 0 50000 0 A 2034-06-12 Common Stock 50000 50000 D The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer. /s/ Alex Levit, Attorney-in-Fact 2024-06-14